Evidence map›Paper›PMID 40917711›Full record

ArticleJournal of surgical case reports2025

ALK-negative retroperitoneal inflammatory myofibroblastic tumor treated conservatively: case report.

Fu-Xiang Lin, Wei Wei, Yi Yu, Yuan Mai, Le Xie, Zhan-Ping Xu

Abstract readCase Reports
In one paragraph

Article in Journal of surgical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Fu-Xiang LinDepartment of Urology, The Eighth Clinical Medical College of Guangzhou University of Chinese Medicine, No. 6 of Qinren Road, Foshan 528000, Guangdong, People's Republic of China.ORCID https://orcid.org/0000-0003-1580-3634
Wei WeiDepartment of Urology, The Eighth Clinical Medical College of Guangzhou University of Chinese Medicine, No. 6 of Qinren Road, Foshan 528000, Guangdong, People's Republic of China.
Yi YuDepartment of Urology, The Eighth Clinical Medical College of Guangzhou University of Chinese Medicine, No. 6 of Qinren Road, Foshan 528000, Guangdong, People's Republic of China.
Yuan MaiDepartment of Urology, The Eighth Clinical Medical College of Guangzhou University of Chinese Medicine, No. 6 of Qinren Road, Foshan 528000, Guangdong, People's Republic of China.
Le XieDepartment of Urology, The Eighth Clinical Medical College of Guangzhou University of Chinese Medicine, No. 6 of Qinren Road, Foshan 528000, Guangdong, People's Republic of China.
Zhan-Ping XuDepartment of Urology, The Eighth Clinical Medical College of Guangzhou University of Chinese Medicine, No. 6 of Qinren Road, Foshan 528000, Guangdong, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 55-year-old female presented with left flank pain and ureteral obstruction. Imaging revealed a retroperitoneal mass suspicious for malignancy. Histopathology confirmed an inflammatory myofibroblastic tumor (IMT; anaplastic lymphoma kinase [ALK]-negative, mouse double minute 2 homolog-positive). Due to vascular encasement prohibiting safe resection, cystoscopic ureteral stenting was performed followed by 12 months of prednisone and celecoxib therapy. Serial imaging showed progressive regression, with near-resolution at 36 months. This demonstrates successful medical management of unresectable ALK-negative retroperitoneal IMT.

Indexed as

ALK-negativecorticosteroidsinflammatory myofibroblastic tumor (IMT)retroperitoneumureteral obstruction

Identifiers

PMID40917711
PMCPMC12411849

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.